ARCHIVES

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

Mass. Public Health Commissioner Koh Named To NCAB; Kovach To Direct Long Island Center.

October 27, 2000